Find a Physician | Courier | Events Calendar | Contact Us | Clinical Trials
Select a Cancer Type:

Grand Rounds

Grand Rounds

Robert H. Lurie Medical Research Center
303 East Superior St.
Searle Conference Room
Chicago Campus
12:00 p.m. - 1:00 p.m. (Wednesdays)
Contact: Denise Marshall - 312.695.1392

April 15
The Search for Truth and Meaning in Genetic Studies of Cancer
Kenan Onel, MD, PhD
Director, Pediatric Familial Cancer Clinic
University of Chicago
Chicago, IL
April 22
Gene Therapy for Hemoglobinopathies
Punam Malik, MD
Marjory J. Johnson Chair of Gene and Cell Therapy
Director, Comprehensive Sickle Cell Program and
Translational Trials Development and Support Laboratory
Cincinnati Children’s Hospital Medical Center
Cincinnati, OH
April 29
Integrating Palliative and Oncology Care: Where Do We Go From Here?
Jennifer Temel, MD
Associate Director, Hematology/Oncology Fellowship Program
Associate Professor, Department of Medicine
Harvard Medical School and Dana-Farber/Partners Cancer Center
Boston, MA
May 6
Fellows Lectures

  1. Randomized, Phase 3 Study Evaluating Safety and Efficacy of the Addition of Carboplatin +/- Veliparib to Standard Neoadjuvant vs. Standard Neoadjuvant Chemotherapy in Subjects with Early Stage Triple Negative Breast Cancer (TNBC)
    Sania Raza, MD
    Division of Hematology/Oncology
    Northwestern University, Feinberg School of Medicine
    Chicago, IL
  2. Drug XL184-308: A Phase 3 Randomized, Controlled Study of Cabozantinib (XKL184) vs. Everolimus in Subjects with Metastatic Renal Cell Carcinoma That Have Progressed After Prior VERGR Tyrosine Kinase Inhibitor Therapy
    Shaina Rozel, MD
    Division of Hematology/Oncology
    Northwestern University, Feinberg School of Medicine
    Chicago, IL
May 13
Understanding and Improving the Quality of Breast Cancer Treatment
Dawn Hershman, MD, MS
Associate Professor
Departments of Medicine and Epidemiology
Co-Director, Breast Cancer Program
Columbia University College of Physicians and Surgeons
New York, NY
May 20
Hemorrhagic Transformation During the Treatment of Ischemic Stroke
Gregory J. del Zoppo, MD
Division of Hematology
Adjunct Professor, Department of Neurology
University of Washington School of Medicine
Seattle, WA
May 27
Complementary Discoveries: PNH, aHUS and APLS
Robert Brodsky, MD
Director, Division of Hematology
Johns Hopkins Kimmel Comprehensive Cancer Center
Baltimore, MD

Accreditation Statement: Northwestern University's Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement: The Northwestern University's Feinberg School of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.